How should carboplatin be dosed and diluted for intravenous administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Carboplatin Dosing and Dilution

Carboplatin should be dosed using the Calvert formula targeting an AUC of 5-6 mg/mL·min (for most combination regimens) and diluted to concentrations between 0.5-10 mg/mL in either 5% dextrose or 0.9% sodium chloride, administered intravenously over 1 hour.

Dosing Methodology

AUC-Based Dosing (Calvert Formula)

Carboplatin is uniquely dosed using the Calvert formula rather than body surface area 1, 2:

Dose (mg) = Target AUC × (GFR + 25)

The target AUC varies by clinical context 3, 4:

  • Standard combination therapy: AUC 5-6 mg/mL·min every 3 weeks
  • Dose-dense regimens: AUC 6 mg/mL·min every 3 weeks
  • Weekly regimens: AUC 2 mg/mL·min weekly
  • Monotherapy or high-risk: AUC up to 7.5 mg/mL·min may be used

Critical Dosing Considerations

GFR Calculation Caveats 1, 5:

  • Cap GFR at 125 mL/min when using the Calvert formula
  • Maximum carboplatin dose should not exceed: AUC (mg·min/mL) × 150 mL/min
  • In obese patients, use actual body weight for Cockcroft-Gault calculation, though this remains controversial 6, 7
  • Carboplatin clearance is directly dependent on renal function; dose reductions are mandatory when creatinine clearance falls below 60 mL/min 5

Important FDA Note: The guidelines reference changes in creatinine methodology that may affect carboplatin dosing calculations 3, 4, 3. Clinicians should verify their institution's creatinine assay calibration.

Dilution and Administration

Preparation Guidelines 5

Carboplatin comes as a 10 mg/mL premixed aqueous solution and can be further diluted:

  • Acceptable diluents: 5% Dextrose in Water (D5W) or 0.9% Sodium Chloride
  • Concentration range: 0.5-10 mg/mL
  • Infusion time: Typically 1 hour (per most regimens) 3, 4
  • Stability: 8 hours at room temperature (25°C) after dilution 5

Critical Dilution Considerations

Avoid chloride-containing solutions when possible 8. While carboplatin can be diluted in 0.9% sodium chloride, there is potential for conversion to cisplatin in chloride-containing solutions. However, recent stability studies show carboplatin in 0.9% NaCl is stable for up to 7 days refrigerated and 3-7 days at room temperature depending on concentration 9.

Stability by concentration 10, 9:

  • 0.2 mg/mL and higher: Stable for 24 hours at room temperature in D5W
  • 0.02 mg/mL: Stability cannot be assured (relevant for desensitization protocols)
  • Standard concentrations (0.5-4 mg/mL): Stable for at least 7 days refrigerated

Practical Administration

Since carboplatin contains no preservative, discard solutions 8 hours after dilution when stored at room temperature 5. For advance preparation, refrigerated storage extends stability but institutional policies typically limit use to 24 hours at room temperature or 3 days refrigerated for safety 9.

Common Regimen Examples

Standard paclitaxel/carboplatin 4:

  • Paclitaxel 175 mg/m² IV over 3 hours
  • Carboplatin AUC 5-6 IV over 1 hour
  • Every 3 weeks × 6 cycles

Dose-dense regimen 4:

  • Paclitaxel 80 mg/m² IV over 1 hour on days 1,8,15
  • Carboplatin AUC 5-6 IV over 1 hour on day 1
  • Every 3 weeks × 6 cycles

Weekly regimen 4:

  • Paclitaxel 60 mg/m² IV over 1 hour
  • Carboplatin AUC 2 IV over 30 minutes
  • Weekly × 18 weeks

Key Pitfalls to Avoid

  1. Never use BSA-based dosing for carboplatin - this leads to unpredictable exposure and toxicity 1, 2

  2. Do not exceed GFR of 125 mL/min in the Calvert formula - this prevents overdosing in patients with excellent renal function 1

  3. Verify renal function before each cycle - carboplatin clearance is entirely dependent on GFR, and acute changes in renal function dramatically affect exposure 5

  4. Prepare fresh solutions when possible - while stability data exists for extended storage, the lack of preservative makes 8-hour room temperature storage the safest approach 5

  5. In obese patients, dosing remains controversial but current evidence suggests using actual body weight in GFR calculations rather than dose capping 1, 6, 7

References

Research

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989

Guideline

ovarian cancer, version 2.2013.

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

Guideline

ovarian cancer, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016

Research

Stability of carboplatin infusion solutions used in desensitization protocol.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019

Related Questions

How should a 700 mg dose of carboplatin be reconstituted, diluted, filtered, and administered intravenously, including infusion volume and premedication considerations?
Can carboplatin induce tremor, and what is the recommended evaluation and management?
Can a total dose of 1000 mg carboplatin be divided into two administrations 21 days apart?
How should carboplatin be dosed and administered in adult cancer patients, including renal function considerations, target AUC, infusion schedule, hydration, anti‑emetic prophylaxis, and monitoring?
Can carboplatin be administered in normal saline?
What medication should be initiated for an 83‑year‑old man with erectile dysfunction, diet‑controlled diabetes mellitus, hypertension, and hyperlipidemia who is active and has no contraindications?
What drug interactions should be considered when prescribing azathioprine (Imuran)?
Is it safe to start a phosphodiesterase‑5 inhibitor for erectile dysfunction in a patient taking losartan 50 mg for hypertension, ezetimibe, fenofibrate, and atorvastatin 80 mg?
When is inpatient psychiatric admission indicated for a patient with anorexia nervosa, based on medical instability (e.g., low body‑mass index, rapid weight loss, electrolyte abnormalities, bradycardia, hypotension, cardiac arrhythmia) and severe psychiatric symptoms (e.g., intense preoccupation with weight, depression, suicidality, inability to care for basic needs)?
Should a 68-year-old woman on diltiazem, spironolactone, chlorthalidone, and lisinopril with an A1C of 6.0%, total cholesterol of 206 mg/dL, and LDL cholesterol of 137 mg/dL be started on a statin?
What is the recommended antibiotic regimen for a 10-year-old child (weight 129.8 lb, BMI 24.36) with streptococcal pharyngitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.